PHILADELPHIA – Shanghai-based Epimab Biotherapeutics Inc. raised $74 million in a series B round to advance its phase I/II lead candidate, EMB-01, and expand its pipeline into immuno-oncology.

PERTH, Australia – Probably nobody was as surprised by the results of Australia's national election than re-elected Liberal Party Prime Minister Scott Morrison, but he has a lot to answer to when it comes to policy initiatives that affect the life sciences sector here.

PERTH, Australia – Probably nobody was as surprised by the results of Australia's national election than re-elected Liberal Party Prime Minister Scott Morrison, but he has a lot to answer to when it comes to policy initiatives that affect the life sciences sector here.

MELBOURNE, Australia – Australia's medical device regulations are undergoing the most extensive changes to the regulations in the last three decades, a top Therapeutic Goods Administration (TGA) official told the AusMedTech conference. That revolutionary rate of change, however, ground to a halt in the last five weeks leading up to the country's national election, with the government now in "caretaker mode," TGA Health Products Regulation Group Deputy Secretary John Skerritt said.

PERTH, Australia – As Australia gets ready for its national election on May 18, the life sciences industry is putting pressure on both political parties to reform the country's research and development tax incentive (RDTI).